Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heinz Jacobs

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
DNA Repair|September 6, 2011
PCNA ubiquitination-independent activation of polymerase η during somatic hypermutation and DNA damage tolerancePeter H L Krijger, Paul C M van den Berk, Niek Wit, et al.
Oncogenesis|July 11, 2024
Gemcitabine as chemotherapy of head and neck cancer in Fanconi anemia patientsAnne M van Harten, Ronak Shah, D Vicky de Boer, et al.
Plos One|January 11, 2019
Towards an understanding of C9orf82 protein/CAAP1 functionMuhammad Assad Aslam, Mir Farshid Alemdehy, Colin E J Pritchard, et al.
Oncotarget|May 4, 2018
Precision cancer therapy: profiting from tumor specific defects in the DNA damage tolerance systemOlimpia Alessandra Buoninfante, Bas Pilzecker, Muhammad Assad Aslam, et al.
Frontiers in Chemistry|March 11, 2020
Strategy for Development of Site-Specific Ubiquitin AntibodiesIla van Kruijsbergen, Monique P C Mulder, Michael Uckelmann, et al.
Frontiers in Immunology|January 24, 2022
Tandem Substitutions in Somatic HypermutationJulieta H Sepúlveda-Yáñez, Diego Alvarez Saravia, Bas Pilzecker, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 21, 2007
A natural hypomorphic variant of the apoptosis regulator Gimap4/IAN1Christine Carter, Carine Dion, Silke Schnell, et al.
Nucleic Acids Research|August 27, 2024
ADARp150 counteracts whole genome duplicationFrank van Gemert, Alexandra Drakaki, Isabel Morales Lozano, et al.
PNAS Nexus|July 3, 2024
Dual role of proliferating cell nuclear antigen monoubiquitination in facilitating Fanconi anemia-mediated interstrand crosslink repairRonak Shah, Muhammad Assad Aslam, Aldo Spanjaard, et al.
DNA Repair|January 29, 2011
HLTF and SHPRH are not essential for PCNA polyubiquitination, survival and somatic hypermutation: existence of an alternative E3 ligasePeter H L Krijger, Kyoo-Young Lee, Niek Wit, et al.
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
DNA Repair|September 6, 2011
PCNA ubiquitination-independent activation of polymerase η during somatic hypermutation and DNA damage tolerancePeter H L Krijger, Paul C M van den Berk, Niek Wit, et al.
Oncogenesis|July 11, 2024
Gemcitabine as chemotherapy of head and neck cancer in Fanconi anemia patientsAnne M van Harten, Ronak Shah, D Vicky de Boer, et al.
Plos One|January 11, 2019
Towards an understanding of C9orf82 protein/CAAP1 functionMuhammad Assad Aslam, Mir Farshid Alemdehy, Colin E J Pritchard, et al.
Oncotarget|May 4, 2018
Precision cancer therapy: profiting from tumor specific defects in the DNA damage tolerance systemOlimpia Alessandra Buoninfante, Bas Pilzecker, Muhammad Assad Aslam, et al.
Frontiers in Chemistry|March 11, 2020
Strategy for Development of Site-Specific Ubiquitin AntibodiesIla van Kruijsbergen, Monique P C Mulder, Michael Uckelmann, et al.
Frontiers in Immunology|January 24, 2022
Tandem Substitutions in Somatic HypermutationJulieta H Sepúlveda-Yáñez, Diego Alvarez Saravia, Bas Pilzecker, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 21, 2007
A natural hypomorphic variant of the apoptosis regulator Gimap4/IAN1Christine Carter, Carine Dion, Silke Schnell, et al.
Nucleic Acids Research|August 27, 2024
ADARp150 counteracts whole genome duplicationFrank van Gemert, Alexandra Drakaki, Isabel Morales Lozano, et al.
PNAS Nexus|July 3, 2024
Dual role of proliferating cell nuclear antigen monoubiquitination in facilitating Fanconi anemia-mediated interstrand crosslink repairRonak Shah, Muhammad Assad Aslam, Aldo Spanjaard, et al.
DNA Repair|January 29, 2011
HLTF and SHPRH are not essential for PCNA polyubiquitination, survival and somatic hypermutation: existence of an alternative E3 ligasePeter H L Krijger, Kyoo-Young Lee, Niek Wit, et al.
Pageof 8